Evidence map›Paper›PMID 28823510›Full record

ReviewTrends in immunology2017

NOD1 and NOD2: Beyond Peptidoglycan Sensing.

A Marijke Keestra-Gounder, Renée M Tsolis

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 2 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Science advances · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

A Marijke Keestra-GounderUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Renée M TsolisDepartment of Medical Microbiology and Immunology, University of California at Davis, School of Medicine, Davis, CA USA. Electronic address: rmtsolis@ucdavis.edu.
University of California Davis Medical Center · USUniversity of Colorado Denver · US

Funding

Innate immune sensing of ER stress during bacterial infectionR01AI109799 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2014 to 2024
$3.6M
Targeting ER Stress in Inflammatory Bowel DiseaseR21AI122092 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KEESTRA-GOUNDER, ARINA MARIJKE · 2016 to 2017
$428k
Detection of bacterial Type IV secretion by the unfolded protein responseR21AI112258 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2014 to 2015
$350k
NIAID NIH HHS R01 AI109799NIAID NIH HHS R21 AI112258NIAID NIH HHS R21 AI122092
6 · The paper itself

Abstract

NOD1 and NOD2 are pattern recognition receptors of the innate immune system with well-established roles in sensing fragments of bacterial peptidoglycan. In addition to their role as microbial sensors, recent evidence indicates that nucleotide-binding oligomerization domains (NODs) can also recognize a broader array of danger signals. Indeed, recent work has expanded the roles of NOD1 and NOD2 to encompass not only sensing of infections with viruses and parasites but also perceiving perturbations of cellular processes such as regulation of the actin cytoskeleton and maintenance of endoplasmic reticulum homeostasis. This review will comment on recent progress and point out emerging questions in these areas.

Indexed as

AnimalsCrohn DiseaseDiabetes Mellitus, Type 2Endoplasmic Reticulum StressHumansNod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinObesityParasitesPeptidoglycanSignal TransductionVirusesNod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinPeptidoglycan

Identifiers

PMID28823510
PMCPMC5624830
OpenAlexW2748353459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.